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Abstract
Background: Up-regulation of the most abundant H family human endogenous retrovirus (HERV-H), especially env-related
transcripts, correlates with colon cancer. However, expression pattern of spliced non-coding transcripts of HERV-H is not
clear.
Methodology/Principal Findings: In this study, expression of HERV-H spliced transcripts in colon cancer was investigated
by a RT-PCR strategy using primers targeting the tRNA
His primer-binding site and the R region in the 39 long terminal repeat
(LTR), followed by cloning and sequencing of the amplicons. Sequences were then assigned to individual HERV-H loci by
employing private nucleotide differences between loci. Different expression patterns of HERV-H spliced transcripts from
distinct active elements were found in colon cancer cell lines HT29, LS 174T, RKO, SW480 and SW620. Furthermore, the
expression patterns in SW480 and RKO were significantly changed by demethylation treatment. Interestingly, more HERV-H
elements were found to be transcriptionally active in colon tumor tissues than in adjacent normal tissues (14 vs. 7).
Conclusions/Significance: This is the first research to study the character of expression of non-coding spliced transcripts of
HERV-H elements in colon cancer. Expression patterns of HERV-H spliced transcripts differed among colon cancer cell lines
and could be affected by genomic DNA methylation levels. More importantly, besides the commonly accepted view of up-
regulation of HERV-H expression in colon tumor tissues, we found more active HERV-H loci in colon tumor as compared with
adjacent normal tissues.
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Introduction
Human endogenous retroviruses (HERVs) constitute 8% of the
human genome [1]. They are inferred to originate from germ-cell
infection by exogenous retroviruses during primate evolution [2].
The proviral structure of HERV elements mainly consists of 59
LTR-gag-pro-pol-env-39 LTR, in which the four genes (gag: group-
specific antigen, pro: protease, pol: polymerase, and env: envelope)
encode structural/functional proteins essential to a replication-
competent retrovirus, and the long terminal repeats (LTR) at both
ends differ HERVs from other retrotransposons such as long
interspersed nuclear elements (LINEs). Most of the remnants of
HERVs are simply isolated LTR copies, with the internal
sequence having been lost during integration or via homologous
recombination. HERV families are defined by different criteria,
such as homogeneity to their exogenous counterparts, sequence
similarity of the pol genes, and the primer binding site (PBS)
immediately downstream of the 59 LTR. H family HERV
(HERV-H) contains a PBS with a sequence similar to human
tRNA
His. There are about one thousand HERV-H elements
throughout the human genome, and most of them (800–900) lack
almost the entire env region [3,4]. It has been reported that only 18
HERV-H elements in the human genome are relatively complete
[5], and only three were identified to contain intact env open
reading frames (ORFs) [6].
Although most of the HERV-H elements are structurally
incomplete due to mutation and deletion during evolution, there
are hundreds of them retaining complete 59 and 39 LTRs and a
PBS-tRNA
His immediately downstream of the 59 LTR [7]. The
expression of HERV elements is mostly under the control of
their LTRs [8]. A complete LTR element has a structure of U3-
R-U5 (59R39), containing both transcription initiating and
terminating signals. The transcription of HERV elements
usually starts from the R region in the 59 LTR and terminates
at the end of the R region in the 39 LTR. It is also proposed that
cell type-dependent expression of HERV elements is usually
controlled by specific regulatory sequences located mainly in the
U3 region [9].
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of HERV-H, many studies focused on the env-related transcripts
[10], and those non-env-related transcripts were rarely paid
attention to. Up-regulation of the most abundant H family
HERV, especially env-related transcripts, has been reported to be
associated with colorectal cancer [5,11,12]. In our previous study,
we observed that there were many spliced non-coding RNA
transcribed from HERV-H elements, both in normal and
cancerous colon tissues, as well as colon cancer cell lines.
However, the expression pattern of the spliced non-coding
transcripts from HERV-Hs is not clear. During the studies on
the three newly identified HERV-H-related genes [13,14,15] in
our laboratory, we observed that the overall expression of HERV-
H elements in colon cancer was complex and different between
tumor samples and adjacent normal samples. We also observed
that many env-deleted HERV-Hs were transcriptionally active, and
many spliced non-coding RNA were transcribed in both tumor
and normal tissues, as well as cancer cell lines. In this study, we
initiated the first study to find out the exact loci of the most active
HERV-H elements in colon cancer.
Results
The RT-PCR-sequencing strategy for hooking HERV-H
non-coding transcripts
Since there are over one thousand members of the HERV-H
family throughout the human genome, with sequences of low
complexity and homologous to one another, it is difficult to study
their transcription profile by taking every member into consider-
ation. In order to profile the expression of HERV-H in colon
cancer cell lines, colon tumor and adjacent normal tissues, and to
identify the exact loci of the most active HERV-H elements, we
developed a RT-PCR-cloning strategy to hook a selected group of
HERV-H-related transcripts. The transcription of HERV ele-
ments is typically started from the 59 R region and terminated at
the end of the 39 R region [16]. We designed the primers by
referring to the sequence of the HERV-H consensus constructed
by Jern et al. [5], with the forward primer targeting the PBS-
tRNA
His downstream of the 59 LTR and the reverse primer
targeting the R region of 39 LTR (Fig. 1A). This pair of primers
was supposed to generate PCR products from HERV-H
transcripts of mixed sizes. Consequently, the total RT-PCR
products were cloned into the pGEM-T Easy vectors and
transfected into E. coli. More than thirty colonies of each sample
were randomly selected and plasmids were then sequenced.
Sequencing results were assigned to specific HERV-H loci based
on private nucleotide differences between individual loci (one or
several nucleotides that are characteristic for an HERV-H locus).
Sequencing results of all the randomly selected colonies indicated
that no inserts were from non-HERV-H transcripts, demonstrat-
ing our strategy worked well.
Expression of HERV-H spliced transcripts in colon cancer
cell lines, and altered expression in response to DNA
demethylation treatment
RT-PCR assays were performed on five colon cancer cell lines,
including HT29, LS 174T, RKO, SW480 and SW620. Different
band patterns were obtained from these cell lines (Fig. 1B left). A
relatively lower level of HERV-H expression was observed in
RKO. It has been reported that there is DNA methylation at a
global genomic level by targeting repetitive sequences [17], so we
further investigated whether demethylation treatment would
change the transcription pattern of HERV-H elements. Cancer
cells were treated with DNA methylation and histone deacetylase
inhibitors (DAC and TSA respectively). RT-PCR results showed
that expression patterns of HERV-H were significantly changed in
SW480 and RKO cells (Fig. 1B right). These findings suggested
that the epigenetic context of a genome affected the expression of
some of the HERV-H elements.
RT-PCR product of each colon cancer cell line was further
analyzed by sequencing after cloning. Sequencing results were
assigned to genomic loci by BLAT searches against the human
Figure 1. RT-PCR detection of HERV-H spliced transcripts in colon cancer cell lines. A. Schematic demonstration of the primer locations.
TSS, transcription start site; TTS, transcription termination site. B. RT-PCR was performed to detect HERV-H spliced transcripts in colon cancer cell lines
with/without demethylation/histone acetylation treatment using the DNA demethylation agent DAC and the histone deacetylase inhibitor TSA. H2O
and genomic DNA mixture (gDNA mix) were used as controls. Genomic DNA mixture produced bands distinct from cDNA samples, which were
reverse transcribed from DNase-treated RNA.
doi:10.1371/journal.pone.0029950.g001
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retrieved and analyzed with RepeatMasker to determine the
HERV-H sequences. Only a limited number of HERV-H
elements were found to be transcriptionally active in each of these
cell lines, with six loci (seven elements) in HT29 and two or three
in each of the other cell lines (Table 1).
Characterization of the active HERV-H elements and their
spliced transcripts in colon cancer cell lines
Pair-wise alignments were performed with the 9.0-kb HERV-H
consensus constructed by Jern et al. to determine the fragment-
deleting patterns of each HERV-H element. Alignment results
showed all the HERV-H elements active in colon cancer cell lines
were structurally incomplete, with the longest one being 6,488 bp
long (Table 1 and Fig. S1). Six fragments were found to be commonly
deleted in these elements, including a short one in the gag region, four
in the polregion, and nearlythe entire envregion (Fig. 2A).There were
some exceptions. The element located at 16q24.1 (active in HT29)
and the one located at 22q11.1 (active in LS 174T) were
extraordinarily short (Fig. 2B). The one at 16q24.1 was only
3,185 bp in length, with the whole gag region and a large fragment
encompassing the pol and env deleted. The one at 22q11.1 was
3,842 bp long, with nearly the entire pol and env regions deleted. Most
of the amplicons (.90%) from LS 174T contained sequences
corresponding to spliced RNAs from the 3.8-kb HERV-H element at
22q11.1, most of which (.60%) were multiply spliced. Interestingly,
two HERV-H elements located at 1p32.3 (2.8 kb separated) were
found to be active in HT29 cells, making use of 59 LTR of the first
HERV-H and 39 LTR of the second one (representative transcript
sequence JK017392). Sequence analysis revealed that 59 LTR was
missing from the latter 2,298-bp HERV-H element (Fig. 2C).
More HERV-H elements were transcriptionally active in
colon tumor than in adjacent normal tissues
Expression of HERV-H transcripts in colon tumor and adjacent
normal tissues were analyzed by RT-PCR. A slight difference
between the RT-PCR products of colon tumor and adjacent
normal samples was observed, with some products of larger sizes
present in tumor samples (Fig. 3). After sequencing and sequence
analysis of the PCR products, 14 HERV-H elements were found
to be transcriptionally active in colon tumor samples. In contrast,
only 7 HERV-H elements were found to be active in the adjacent
normal colon samples. Details of these HERV-H elements were
indicated in Table 2. Sequence analysis by pair-wise alignment
against the HERV-H consensus revealed that all the active
HERV-H elements were structurally incomplete, with six
fragments commonly deleted as indicated in Fig. 2A (Fig. S2).
Four HERV-H elements, located at 1q42.2, 16q24.1, 19q13.31
and 5q23.2 respectively, were active in both tumor and adjacent
normal tissues. We further analyzed the transcript abundance
from each active HERV-H element. Interestingly, three of the
commonly active elements (located at 1q42.2, 16q24.1 and
19q13.31) each contributed to more than 10% of the transcripts
in both tumor and adjacent normal samples. There was another
element, located at 1p31.3, producing more than 10% of the
transcripts in tumor. The four most active elements in the tumor
sample, i.e. those located at 1q42.2, 16q24.1, 19q13.31 and
1p31.3, in total contributed to 68.89% of the transcripts in the
tumor sample. By contrast, the three most active elements in
normal samples (located at 1q42.2, 16q24.1 and 19q13.31)
contributed to 85.71% of the overall transcripts. These results
indicated that there were more HERV-H elements active in colon
tumor tissues than in adjacent normal tissues. Furthermore, the






HT29 1p32.3* Chr1+: (53890009–53895701),(53898553–53900850) (5693),(2298) 426, Gag protein
2p14 Chr22: 69670143–69676473 6331 540, Polymerase
3q28 Chr3+: 189862389–189867991 5603 900, partial Gag protein
14q24.3 Chr14+: 74170042–74175916 5875
16q24.1** Chr16+: 86311701–86314885 3185 495, Integrase; 618, conserved domain RT-like
19q13.32 Chr192: 47553126–47558666 5541
LS174T 22q11.1 Chr22+: 17092198–17096039 3842 825, Gag protein
19q13.31** Chr192: 43827663–43833536 5874
RKO 3q24 Chr3+: 145428282–145433882 5601
6q24.1 Chr6+: 142336803–142342919 6117 525, conserved domain CREB5
19q13.41 Chr19+: 53131048–53136648 5601
SW480 1q25.3 Chr1+: 183582345–183588508 6164
6q24.2 Chr6+: 145244311–145249992 5682
20p12.1** Chr202: 12320915–12326587 5673
SW620 1q25.3 Chr1+: 183582345–183588508 6164
5q31.1 Chr52: 135066688–135073175 6488 528, Gag protein; 747, conserved domain RT-like
*Two adjacent HERV-H elements at 1p32.3 were combinedly active by making use of 59 LTR of the first HERV-H and 39 LTR of the second one (representative transcript
sequence JK017392).
**The elements located at 16q24.1 and 19q13.31 are also actively transcribed in both tumor and adjacent normal colon tissues, while the one located at 20p12.1 is
active in tumor tissue.
***Open reading frames (ORFs) were predicted by the online program ORF Finder and putative peptide sequences were subjected to Blastp search against the Non-
redundant protein sequences at http://www.ncbi.nlm.nih.gov/. Only predicted ORFs$303 nt (peptide sequence $100 aa) and with Blastp matches are included. Gag,
group-specific antigen; RT, Reverse transcriptase; CREB5, cAMP response element-binding protein 5.
doi:10.1371/journal.pone.0029950.t001
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from fewer HERV-H elements when compared with tumor
samples.
Discussion
Due to the abundance of HERV-H elements in the human
genome and their high sequence similarity to each other, there
seems to be no appropriate approach to investigating the genome-
wide transcription profile of HERV-H elements while at the same
time taking each element into consideration individually. Although
findings of this study did not represent the overall actual genome-
wide expressional profile of HERV-H elements, we took the
advantage of the PCR enrichment strategy to hook the most active
HERV-H elements that produced transcripts containing the PBS-
tRNA
His and 39 R regions, and successfully identified the exact
Figure 2. Characterization of the active HERV-H elements in colon cancer cell lines and their spliced transcripts. A. Schematic of the
six commonly deleted regions in the active HERV-H elements in colon cancer cell lines. B. Schematics of the two extraordinarily short HERV-H
elements and their transcripts. Pair-wise alignments for each HERV-H element were performed with the HERV-H consensus constructed by Jern P, et
al. The shortened alignment results were shown to indicate the missing regions precisely. Color density represents the extent of homology with the
HERV-H consensus. Gray areas represent deleted regions in the HERV-H elements as compared with the HERV-H consensus. Spliced transcripts are
shown above the alignment results accordingly. Thick bars represent exons, and lines represent introns. Regions of LTRs, pre-gag, gag, pro, pol and
env are labeled below. C. Schematics of the two combinedly active HERV-H elements located at 1p32.3 in HT29.
doi:10.1371/journal.pone.0029950.g002
Figure 3. Gel electrophoresis of RT-PCR products of HERV-H-
related transcripts in colon tumor and adjacent normal tissues.
M, DL2000 ladder; T, tumor; N, normal.
doi:10.1371/journal.pone.0029950.g003
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samples. Expression patterns of HERV-H spliced transcripts from
HERV-H elements were different among colon tumor, adjacent
normal samples, and colon cancer cell lines.
Expression patterns of HERV-Hsplicedtranscripts from HERV-
H elements were different among the five colon cancer cell lines
tested, evidenced by both gel electrophoresis of the RT-PCR
products (Fig. 1B left) and sequencing of the amplicons after cloning
(Table 1). Sequence analysis by comparing them with the
constructed HERV-H consensus indicated that the active HERV-
H elements found in this study were all structurally incomplete to
some extent. This can also be inferred from the lengths, all of which
were much shorter than the full-length HERV-H consensus (9.0-
kb). The band patterns were different between SW480 and SW620
cells. Although they originated from the primary and metastatic
tumors of the same patient, this difference between SW480 and
SW620 may be just due to long-term culture. Likewise, the limited
number of active HERV-H elements in each cell line may also be
due to long-term culture in defined in vitro conditions. It is also
interesting that bydemethylation treatment usingDNAmethylation
and histone deacetylase inhibitors, expression patterns in RKO and
SW480 cells were changed significantly, suggesting that transcrip-
tion of some HERV-H elements are regulated epigenetically.
Although no obvious difference was observed in the RT-PCR
product bands between tumor and adjacent normal samples, the
total numbers and loci of active HERV-H elements were
significantly different (Fig. 3; Table 2). Seven HERV-H elements
were found to be transcriptionally active in the adjacent normal
colon samples. By comparison, 14 elements were found to be
active in the tested colon tumor tissues. Expression of the three
commonly most active elements (.10%) seemed to be ordinary;
the one located at 1q24.2 produced 17.78% and 26.19% of the
products in tumor and normal samples, and products from the one
located at 16q24.1 consisted of 26.67% in tumor and 16.67% in
normal samples, respectively. Interestingly, the one element
located at 19q13.31 was the most active in adjacent normal
tissues, producing 42.86% of the products, while only 11.11%
from tumor samples belonged to 19q13.31. These results
demonstrated that most of the HERV-H spliced transcripts in
adjacent normal colon tissues were from 19q13.31, while
transcripts in colon tumor tissues involved more elements.
All active HERV-H elements found in this study are structurally
incomplete, with six fragments commonly deleted, which are
distributed through the gag, pol and env regions (Fig. 2A); even so,
some of them (40%) retain putative open reading frames (ORFs)
(Tables 1 and 2; Fig. S1 and S2). Although some of these putative
Table 2. The loci of active HERV-Hs in colon tumor and adjacent normal tissues.
Colon





Tumor T1 1q42.2 Chr1+: 230736962–230744940 7979 17.78% 68.89% 399, conserved domain RT-like; 402, Envelope
T2 16q24.1 Chr16+: 86311701–86314885 3185 26.67% 618, conserved domain RT-like
T3 19q13.31 Chr192: 43827663–43833536 5874 11.11% 318, CREB5
T4 1p31.3 Chr1+:68851687–68857675 5989 13.33%
T5 2p12 Chr22: 76800751–76806830 6080
T6 3q26 Chr3+: 189862389–189867991 5603
T7 8q22.2 Chr8+: 100955923–100961835 5913
T8 11q24.2 Chr112:127638814–127644790 5977 741, Polymerase
T9 13q33.3 Chr13+: 109917438–109923464 6027 327, Protease
T10 20p12.1 Chr202: 12320915–12326587 5673
T11 5q23.2 Chr52: 121809921–121814541 4621 59LTR incomplete
T12 Xp22.32 ChrX2: 4458515–4464361 5847 HERV-HX**
T13 1q31.3 chr12:195817044–195817727 684 59LTR-39LTR***
T14 12p12.2 Chr122:20970842–20975551 4710 39LTR missing 327, conserved domain Protease;
309, conserved domain RT-like
Adjacent
Normal
N1 1q42.2 Chr1+: 230736962–230744940 7979 26.19% 85.71% (as T1)
N2 16q24.1 Chr16+: 86311701–86314885 3185 16.67% (as T2)
N3 19q13.31 Chr192: 43827663–43833536 5874 42.86% (as T3)
N4 4p15.2 Chr42: 23724496–23729489 4994
N5 19q13.12 Chr192:36750410–36756122 5713 309, conserved domain RT-like
N6 Xq23 ChrX2: 115854285–115860680 6396 564, Gag protein
N7 5q23.2 Chr52: 121809921–121814541 4621 (as T11)
*Active elements individually contributing to more than 10% of the transcripts in tumor or adjacent normal samples are highlighted in boldface and their transcript
abundances are indicated in the ‘Abundance’ column (individual and total, respectively).
**HERV-HX is the colon cancer-related HERV-H element identified by us previously [14]. Inserts of PCR product clones were all HERV-HX fragments but not spliced
sequences, in concordance with our previous finding that no spliced transcripts were produced from HERV-HX in colon tumor samples.
***The element located at 1q31.3 consists of 59LTR and 39LTR, with the entire protein coding region (gag-pro-pol-env) missing.
****Open reading frames (ORFs) were predicted by the online program ORF Finder and putative peptide sequences were subjected to Blastp search against the Non-
redundant protein sequences at http://www.ncbi.nlm.nih.gov/. Only predicted ORFs$303 nt (peptide sequence $100 aa) and with Blastp matches are included. RT,
Reverse transcriptase; CREB5, cAMP response element-binding protein 5; Gag, group-specific antigen.
doi:10.1371/journal.pone.0029950.t002
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when compared with the corresponding region in the HERV-H
consensus, seven of the putative peptide sequences (encoded by 6
HERV-H elements) contain conserved domains, with one
conserved Protease domain, one conserved CREB5 (cAMP
response element-binding protein 5) domain and five conserved
reverse transcriptase (RT)-like domains. Interestingly, all the three
commonly most active HERV-H elements (located at 1q42.2,
16q24.1 and 19q13.31) in tumor and adjacent normal tissues
contain putative ORFs with conserved domains (Table 2; Fig. S2).
Whether these ORFs actually produce proteins in colon tissues
and what role they play in colon carcinogenesis are issues to be
addressed.
The reason for the transcriptional difference in HERV-H
elements between colon tumor and adjacent normal tissues
remains unknown. Cells in tumor and adjacent normal samples
are different in many aspects. Colon tumor cells in a sample are
heterogeneous and cover more phases of the cell cycle, while non-
tumor cells are usually in G0. However, there has been no study to
address whether HERVs are expressed in a cell cycle dependent
manner yet. Furthermore, tumor cells are in a more undifferen-
tiated state as compared with non-tumor cells, reminiscent of the
state of embryonic cells. Expression of HERVs in a tissue-specific
and developmental stage-dependent manner has been reported
[18]. HERV elements have also been found to be highly expressed
in reproductive tissues such as testis and placenta, which contain
undifferentiated cells [5,19]. Whether HERV-H elements are
expressed in a differentiation dependent manner, subsequently
causing the difference between colon tumor and adjacent normal
tissues, also needs to be investigated. These two points may
indicate directions for further study on the mechanism by which
HERV-H elements are differentially regulated between colon
tumor and adjacent normal tissues.
This is the first attempt to study the characteristics of expression
of HERV-H spliced transcripts in colon cancer. In summary, our
results indicated that expression patterns of HERV-H elements
differed among colon cancer cell lines and could be affected by
demethylation treatment. More importantly, our findings demon-
strated that HERV-H expression involved more active HERV-H
elements in colon tumor than in adjacent normal tissues.
Materials and Methods
Ethics statement
This study was approved by the ethics committee of Zhejiang
University, and written consents were obtained from all patients
involved.
Tissue samples, cell culture and RNA preparation
Colon tumor and adjacent normal tissue samples were obtained
after surgical resection in the second affiliated hospital of Zhejiang
University and stored frozen at 280uC until RNA extraction.
Tissue types (tumor or normal) were assessed by histological
staining. Cancer cells were obtained from American Type Culture
Collection and grown in RPMI 1640 medium supplemented with
10% fetal calf serum. Total RNA was prepared with Trizol
reagent (Invitrogen) according to the manufacturer’s guide. RNA
was always treated with RQ1 RNase-free DNase (Promega) before
cDNA synthesis to eliminate genomic DNA contamination.
Demethylation treatment with DNA methylation and
histone deacetylase inhibitors
Cells were treated with the DNA methylation inhibitor 5-aza-
29-deoxycytidine (DAC; Sigma) and the histone deacetylase
inhibitor trichostatin A (TSA; Beyotime) as described [20]: initial
treatment with DAC (200 nM) for 48 h, with drug and medium
replaced 24 h after the beginning of treatment, followed by the
replacement of medium containing TSA (300 nM) for a further
24 h. Total RNA from drug treated cells or non-treated cells was
isolated with Trizol reagent and treated with DNase before cDNA
synthesis.
Reverse transcription-PCR (RT-PCR)
RNA was reverse-transcribed into cDNA using M-MLV
Reverse Transcriptase (Promega) according to the manufacturer’s
guide. PCR assays were performed with Taq DNA polymerase
(Promega) in reaction systems containing 0.2 mmol/L forward and
reverse primers each. Thermal cycler parameters were 94uC
5 min, (94uC3 0s ,5 5 uC3 0s ,7 2 uC9 0s ) 636 cycles, 72uC 10 min.
PCR products of each cell sample, PCR product mixture of six
tumor samples and PCR product mixture of six adjacent normal
samples were purified with AxyPrep PCR Cleanup kit (Axygen),
cloned into the pGEM-T easy vector (Promega) and transfected
into E. coli bacteria. Over 30 colonies from each cell sample and
100 colonies from tumor or normal tissue samples were subjected
to Sanger sequencing. Targets of the primers are indicated in
Fig. 1A and their nucleotide sequences are as follows: forward
(targeting PBS-tRNA
His): 59-TGGTGCCGTGACTCGGAT-39,
reverse (targeting R region): 59-GCTGAGTCCGAAAAGA-
GAGTC-39. The primers were designed by referring to the
HERV-H consensus constructed by Jern et al. [5], with ‘‘G’’ in the
forward primer modified according to genome-wide sequence
analysis on HERV-H-related primer binding sites on our own (not
shown).
Sequence analysis
Sequences were searched with BLAT method against human
genome using the online server (http://genome.ucsc.edu/cgi-bin/
hgBlat?command=start). Sequencing results were excluded if the
sequences in-between the primers had more than five dissimilar-
ities to genomic DNA. Genomic DNA sequences were retrieved
from the human genome assembly (hg19) at http://genome.ucsc.
edu/cgi-bin/hgGateway. Sequences were analyzed with the
tool RepeatMasker at http://www.repeatmasker.org/cgi-bin/
WEBRepeatMasker to identify repeat elements. Pairwise align-
ments were carried out with GeneDoc. ORF prediction was
performed using the online program ORF Finder (http://www.
ncbi.nlm.nih.gov/gorf/gorf.html). Then putative amino acid
sequences were blasted against the non-redundant protein
sequence database using the online BLASTP program (http://
blast.ncbi.nlm.nih.gov/Blast.cgi).
Sequence submission
A total of 92 nucleotide sequences of the newly identified
HERV-H spliced transcripts have been deposited in dbEST with
accession numbers of JK017330–JK017415 and JK475044–
JK475049 (with 7 EST library accession numbers of LIB-
EST_027280 - 027286).
Supporting Information
Figure S1 Pair-wise alignments for each HERV-H
element were performed with the HERV-H consensus
constructed by Jern P, et al. The shortened alignment results
are shown to indicate the missing regions precisely. Color density
represents the extent of homology with the HERV-H consensus.
Lines represent deleted regions in the HERV-H elements as
compared with the HERV-H consensus. Red rectangles indicate
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PLoS ONE | www.plosone.org 6 January 2012 | Volume 7 | Issue 1 | e29950the regions where putative ORFs are harbored, while red
rectangles with thick lines indicate ORFs with conserved domains.
Regions of LTRs, pre-gag, gag, pro, pol and env are labeled below.
Genomic locus of each HERV-H element is indicated corre-
spondingly on the right side.
(TIF)
Figure S2 Pair-wise alignments for each HERV-H
element were performed with the HERV-H consensus
constructed by Jern P, et al. The shortened alignment results
are shown to indicate the missing regions precisely. Color density
represents the extent of homology with the HERV-H consensus.
Lines represent deleted regions in the HERV-H elements as
compared with the HERV-H consensus. Red rectangles indicate
the regions where putative ORFs are harbored, while red
rectangles with thick lines indicate ORFs with conserved domains.
Regions of LTRs, pre-gag, gag, pro, pol and env are labeled below.
Genomic locus of each HERV-H element is indicated corre-
spondingly on the right side. The number of each element is
shown on the left as indicated in Table 2.
(TIF)
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